Condition: Pneumonia, Ventilator-Associated · Respiratory Tract Infections · Prognosis · Sponsor: The First Affiliated Hospital with Nanjing Medical University
We are using a tool called QtNGS (quantitative targeted amplicon-based next-generation sequencing ) to measure the abundance of local pathogens in patients with ventilator-associated lower respiratory tract infections. We hypothesize that changes in pathogen abundance before and after treatment are related to patient outcomes. This study aims to evaluate the effectiveness of the tool by analyzing the changes in pathogen abundance and exploring the relationship between these changes and clinical outcomes.
This description comes directly from the study's public registry record.
Wenkui Sun, Dr · +86 13914742215 · sunwenkui@njmu.edu.cn
Ji Zhou, Dr · +86 13951621810 · zhoujinjmu@126.com
Always discuss trial participation with your own doctor first.
| he First Affiliated Hospital of Nanjing Medical University | Nanjing, Jiangsu, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06467864